1. Home
  2. NSP vs COLL Comparison

NSP vs COLL Comparison

Compare NSP & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$38.55

Market Cap

1.7B

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$48.67

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
COLL
Founded
1986
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
NSP
COLL
Price
$38.55
$48.67
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$47.67
$47.50
AVG Volume (30 Days)
910.8K
498.8K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
6.24%
N/A
EPS Growth
N/A
N/A
EPS
0.45
1.63
Revenue
$6,757,000,000.00
$757,067,000.00
Revenue This Year
$4.71
$26.35
Revenue Next Year
$6.40
$3.67
P/E Ratio
$85.99
$29.92
Revenue Growth
3.19
26.34
52 Week Low
$31.00
$23.23
52 Week High
$95.98
$49.16

Technical Indicators

Market Signals
Indicator
NSP
COLL
Relative Strength Index (RSI) 57.67 70.71
Support Level $34.14 $46.15
Resistance Level $36.32 $49.16
Average True Range (ATR) 1.32 1.32
MACD 0.84 -0.16
Stochastic Oscillator 90.83 92.11

Price Performance

Historical Comparison
NSP
COLL

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: